RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Case For Cognitive Assessments In Phase 1 Clinical Trials
Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
Navigating The Complexities Of Publication Planning
In the dynamic landscape of the life sciences industry, Medical Affairs (MA) teams and accessible digital platforms are pivotal in navigating the complexities of medical publication planning.
-
Balancing Clinical Care With Digital Utility In Hybrid Trials
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Building Patient-Focused eCOA Strategies: Insights And Best Practices
Discover why the use of electronic clinical outcome assessments (eCOA) in clinical research is becoming an increasingly important part of study design in this article.
-
ePROM Implementation: 4 Best Practices For System Functionality
Explore four of the 15 system functionality considerations highlighted in an eCOA Consortium article that aim to create a more thorough and standardized approach to ePROM implementation.
-
AI Needs A Home: Inside The Workflows That Drive Trials
Move beyond fragmented digital tools. Learn how a governed execution layer transforms AI into a collaborator, streamlining trial decisions and creating a traceable record of human-AI insight.
-
Shaping The Future Of eCOA User Acceptance Testing
Proactive planning by sponsors and early User Acceptance Testing (UAT) involvement in the eCOA design process can substantially improve study quality, efficiency, and consistency.
-
What Universalized Terminology Means For Decentralized Research
Many DCT stakeholders have attempted to release terminology guides as it relates to their own dealings, however, there had never been a wide range of universalized DCT terms until now.
-
What Is eCOA And How Does It Improve Clinical Trial Data Quality?
Discover how eCOA data capture can improve clinical trials by providing improved data quality, regulatory compliance, and accelerated clinical development.
-
The Transformative Role Of Digital Health Technologies
Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working